RVL Pharmaceuticals plc Accounts Payable, Trade, Current
RVL Pharmaceuticals plc had Accounts Payable, Trade, Current of $2.53 million as of 2023-06-30, per its 10-Q filed 2023-08-14.
Discontinued › Notes › Payables and Accruals › Accounts Payable and Accrued Liabilities, Current
us-gaap:AccountsPayableTradeCurrent · last filed 2023-08-14
- 2023-06-30: Accounts Payable, Trade, Current $2.53M.
- 2023-03-31: Accounts Payable, Trade, Current $2.63M.
- 2022-12-31: Accounts Payable, Trade, Current $2.41M.
- 2022-09-30: Accounts Payable, Trade, Current $7.00M.
| Period end | Accounts Payable, Trade, Current | Accounts Payable, Trade, Current as first filed |
|---|---|---|
| 2023-06-30 | $2.53M 10-Q · filed 2023-08-14 | |
| 2023-03-31 | $2.63M 10-Q · filed 2023-05-11 | |
| 2022-12-31 | $2.41M 10-Q · filed 2023-08-14 | |
| 2022-09-30 | $7.00M 10-Q · filed 2022-11-10 | |
| 2022-06-30 | $5.44M 10-Q · filed 2022-08-11 | |
| 2022-03-31 | $4.73M 10-Q · filed 2022-05-12 | |
| 2021-12-31 | $3.78M 10-K · filed 2023-03-20 | |
| 2021-09-30 | $4.45M 10-Q · filed 2021-11-15 | |
| 2021-06-30 | $1.55M 10-Q · filed 2021-08-16 | |
| 2021-03-31 | $4.52M 10-Q · filed 2021-05-13 | |
| 2020-12-31 | $3.13M 10-K · filed 2022-03-30 | $6.77M 10-K · filed 2021-03-30 |
| 2020-09-30 | $7.91M 10-Q · filed 2020-11-10 | |
| 2020-06-30 | $8.80M 10-Q · filed 2020-08-11 | |
| 2020-03-31 | $8.78M 10-Q · filed 2020-05-12 | |
| 2019-12-31 | $1.49M 8-K · filed 2021-09-08 | $8.49M 10-K · filed 2020-03-19 |
| 2019-09-30 | $9.91M 10-Q · filed 2019-11-14 | |
| 2019-06-30 | $18.92M 10-Q · filed 2019-08-08 | |
| 2019-03-31 | $20.59M 10-Q · filed 2019-05-09 | |
| 2018-12-31 | $24.87M 10-K · filed 2020-03-19 | $24.87M 10-K · filed 2019-03-28 |
| 2018-09-30 | $27.86M 10-Q · filed 2018-11-08 | |
| 2017-12-31 | $36.07M 8-K · filed 2019-12-20 |